OBI Pharma announces COVID-19 vaccine clinical trials to start in 2022
02/08/2022 08:38 PM
Taiwan-based biotech firm OBI Pharma Inc. announced Tuesday that the COVID-19 vaccine it developed called BCVax will enter phase 1 & 2 clinical trials in the second half of this year.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Chiayi man sentenced to 14.5 year for killing neighbor over noise dispute
05/09/2025 06:17 PM - Business
TSMC reports record monthly revenue in April
05/09/2025 05:34 PM - Business
U.S. dollar closes higher on Taipei forex market
05/09/2025 04:13 PM - Politics
Taiwan medical groups urge WHO to invite Taiwan to WHA as observer
05/09/2025 03:12 PM - Culture
Taiwanese architecture exhibition opens in Venice
05/09/2025 02:50 PM